In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Aneurysmal Acute Subdural Hemorrhage: Evaluation and Treatment

    Final Number:
    1288

    Authors:
    Charles Glen Kulwin MD; Aaron A. Cohen-Gadol MD

    Study Design:
    Clinical Trial

    Subject Category:

    Meeting: Congress of Neurological Surgeons 2013 Annual Meeting

    Introduction: Acute subdural hematoma (SDH) is an uncommon presentation of aneurysmal hemorrhage that has been identified as a poor prognostic sign. Current series are small, have short follow-up and/or were collected over a long period during which treatment has evolved. We present a large modern series of aneurysmal SDH with long-term follow-up, and evaluate prognostic factors for good outcome.

    Methods: A prospectively maintained database was queried for all patients presenting with aneurysmal SDH from 2000-present. Thirty patients met criteria and were analyzed. Statistical analysis was performed with unpaired t-test or Fisher’s exact test when appropriate.

    Results: Average age was 61. Average Hunt-Hess (HH) was 3.8. Average initial SDH thickness was 6.7mm; average midline shift was 5.9mm. 21 SDHs were on the right, 26 presented with subarachnoid hemorrhage and 19 harbored intraparenchymal hematoma. 18 underwent open surgical treatment, 8 received endosaccular coiling, one underwent both, and three were not treated due to poor status. Good (Glascow Outcome Scale, GOS 4-5) discharge condition occurred in 20% of patients and increased to 40% at 6-12 months. Good clinical presentation (HH 1-2) had a good outcome in 75%. Poor clinical presentation (HH 4-5) had a good outcome in 30%. Good outcome correlated with younger age (p=0.04), smaller aneurysm size (p=0.04) and HH at intervention (p=0.04); it did not correlate with gender, race, admission HH, subarachnoid or intraparenchymal hemorrhage, size or laterality of hemorrhage, midline shift or treatment modality (p>0.15).

    Conclusions: Aneurysmal SDH presents with poor clinical grade; however, even poor grade presentation can ultimately result in good outcome in nearly a third of cases, suggesting that clinical presentation may be exaggerated by the hematoma. Clinical grade and age were predictors of outcome; laterality, size of hematoma, and midline shift were not, suggesting that clinical status is more important than radiographic findings.

    Patient Care: This study will affect the initial evaluation and management decisions for this patient population, especially regarding long-term outcome of aggressive treatment.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) Recognize the uncommon presentation of acute SDH as a manifestation of aneurysmal hemorrhage, 2) Understand the clinical presentation, general treatment options and outcomes for aneurysmal SDH, 3) Describe prognostic factors for outcome in aneurysmal SDH.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy